Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

ARKC vs. ARKG: which is better?

Bottom line

ARKC vs ARKG: the short answer

ARKC (ARK 21Shares Active On-Chain Bitcoin Strategy ETF) and ARKG (ARK Genomic Revolution ETF) are both etfs.

Updated Nov 19, 2026

ARKC vs ARKG side by side

ARKCARKG
TypeETFETF
Fund familyARK InvestARK Invest
CategoryCrypto & Digital AssetsHealth Care Sector
Expense ratio—0.75%
Annual cost per $10k—$75
10-yr cost on $10k (prospectus)—$930
Max front loadNoneNone
12b-1 fee—0%
1-yr return—−28.1%
5-yr return (annualized)—−6.5%
10-yr return (annualized)—+1.9%
Best quarter—+66.0%
Worst quarter—−31.5%
Net assets (fund)—$1.6B
Number of holdings—33
Portfolio turnover—33%
Returns as of—Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

ARKC and ARKG share none of their top holdings.

ARKC top 10

    ARKG top 10

    1. 10x Genomics Inc — 9.39%
    2. Twist Bioscience Corp — 7.73%
    3. Tempus Ai Inc — 6.56%
    4. Crispr Therapeutics Ag — 6.29%
    5. Personalis Inc — 5.47%
    6. Absci Corp — 5.14%
    7. Guardant Health Inc — 4.74%
    8. Illumina Inc — 4.74%
    9. Eli Lilly & Company — 4.68%
    10. Caredx Inc — 4.30%

    FAQ

    What is the difference between ARKC and ARKG?
    ARKC (ARK 21Shares Active On-Chain Bitcoin Strategy ETF) and ARKG (ARK Genomic Revolution ETF) are both etfs.
    Should I own both ARKC and ARKG?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.